help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofseth, L. J.
Right arrow Articles by Haslam, S. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofseth, L. J.
Right arrow Articles by Haslam, S. Z.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 12 4559-4565
Copyright © 1999 by The Endocrine Society

Original Studies

Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation in the Normal Postmenopausal Breast1

Lorne J. Hofseth, Ahmed M. Raafat, Janet R. Osuch, Dorothy R. Pathak, Carol A. Slomski and Sandra Z. Haslam

Departments of Physiology (L.J.H., A.M.R., S.Z.H.), Surgery (J.R.O., C.A.S.), and Epidemiology (D.R.P.), Michigan State University, East Lansing, Michigan 48824

Address correspondence and requests for reprints to: Sandra Z. Haslam, Ph.D., Department of Physiology, 108 Giltner Hall, Michigan State University, East Lansing, Michigan 48824. E-mail: shaslam{at}pilot.msu.edu

The relative effects of postmenopausal hormone replacement therapy (HRT) with estrogen alone vs. estrogen+progestin on breast cell proliferation and on breast cancer risk are controversial. A cross-sectional observational study was carried out to examine the proliferative effects of HRT with estrogen or estrogen plus the progestin, medroxyprogesterone acetate, in breast tissue of postmenopausal women. Benign breast biopsies from 86 postmenopausal women were analyzed with antiproliferating cell nuclear antigen (anti-PCNA) and Ki67 antibodies to measure relative levels of cell proliferation. Epithelial density and estrogen and progesterone receptor status were also determined. The women were categorized either as users of: 1) estrogen (E) alone; 2) estrogen+medroxyprogesterone acetate (E+P); or 3) no HRT. Compared with no HRT, the breast epithelium of women who had received either E+P or E alone had significantly higher PCNA proliferation indices, and treatment with E+P had a significantly higher index (PCNA and Ki67) than treatment with E alone. Breast epithelial density was significantly greater in postmenopausal women treated with E and E+P, compared with no HRT. Thus, the present study shows that postmenopausal HRT with E+P was associated with greater breast epithelial cell proliferation and breast epithelial cell density than E alone or no HRT. Furthermore, with E+P, breast proliferation was localized to the terminal duct-lobular unit of the breast, which is the site of development of most breast cancers. Further studies are needed to assess the possible association between the mitogenic activity of progestins and breast cancer risk.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Behera, Q. Dai, R. Garde, C. Saner, E. Jungheim, and T. M. Price
Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1089 - E1096.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. J. Crandall, A. K. Aragaki, R. T. Chlebowski, A. McTiernan, G. Anderson, S. L. Hendrix, B. B. Cochrane, L. H. Kuller, and J. A. Cauley
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
Arch Intern Med, October 12, 2009; 169(18): 1684 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. P. Lydon and D. P. Edwards
Finally! A Model for Progesterone Receptor Action in Normal Human Breast
Endocrinology, July 1, 2009; 150(7): 2988 - 2990.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Messina and A. H Wu
Perspectives on the soy-breast cancer relation
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1673S - 1679S.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. D. Aupperlee, A. A. Drolet, S. Durairaj, W. Wang, R. C. Schwartz, and S. Z. Haslam
Strain-Specific Differences in the Mechanisms of Progesterone Regulation of Murine Mammary Gland Development
Endocrinology, March 1, 2009; 150(3): 1485 - 1494.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Fabre, A. Fournier, S. Mesrine, A. Gompel, J. Desreux, F. Berrino, M.-C. Boutron-Ruault, I. Romieu, and F. Clavel-Chapelon
Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2723 - 2728.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Otto, I. Fuchs, H. Altmann, M. Klewer, A. Walter, K. Prelle, R. Vonk, and K.-H. Fritzemeier
Comparative Analysis of the Uterine and Mammary Gland Effects of Drospirenone and Medroxyprogesterone Acetate
Endocrinology, August 1, 2008; 149(8): 3952 - 3959.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Fournier, A. Fabre, S. Mesrine, M.-C. Boutron-Ruault, F. Berrino, and F. Clavel-Chapelon
Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor-Defined Invasive Breast Cancer
J. Clin. Oncol., March 10, 2008; 26(8): 1260 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
N. Biglia, L. Mariani, L. Sgro, P. Mininanni, G. Moggio, and P. Sismondi
Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment
Endocr. Relat. Cancer, September 1, 2007; 14(3): 549 - 567.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Kariagina, M. D. Aupperlee, and S. Z. Haslam
Progesterone Receptor Isoforms and Proliferation in the Rat Mammary Gland during Development
Endocrinology, June 1, 2007; 148(6): 2723 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. D. Aupperlee and S. Z. Haslam
Differential Hormonal Regulation and Function of Progesterone Receptor Isoforms in Normal Adult Mouse Mammary Gland
Endocrinology, May 1, 2007; 148(5): 2290 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. J.B. van Duijnhoven, P. H.M. Peeters, R. M.L. Warren, S. A. Bingham, P. A.H. van Noord, E. M. Monninkhof, D. E. Grobbee, and C. H. van Gils
Postmenopausal Hormone Therapy and Changes in Mammographic Density
J. Clin. Oncol., April 10, 2007; 25(11): 1323 - 1328.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. M. Zhang, J. E. Manson, K. M. Rexrode, N. R. Cook, J. E. Buring, and I-M. Lee
Use of Oral Conjugated Estrogen Alone and Risk of Breast Cancer
Am. J. Epidemiol., March 1, 2007; 165(5): 524 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
V. Boonyaratanakornkit, E. McGowan, L. Sherman, M. A. Mancini, B. J. Cheskis, and D. P. Edwards
The Role of Extranuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle
Mol. Endocrinol., February 1, 2007; 21(2): 359 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Zhu, L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones
Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor Cells
Cancer Res., August 15, 2006; 66(16): 7991 - 7998.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. D. Yager and N. E. Davidson
Estrogen Carcinogenesis in Breast Cancer
N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
C. A. Sartorius, D. M.E. Harvell, T. Shen, and K. B. Horwitz
Progestins Initiate a Luminal to Myoepithelial Switch in Estrogen-Dependent Human Breast Tumors without Altering Growth
Cancer Res., November 1, 2005; 65(21): 9779 - 9788.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Saitoh, M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, M. Doshida, T. Takahashi, H. Igarashi, A. Mori-Abe, B. Du, et al.
Medroxyprogesterone Acetate Induces Cell Proliferation through Up-Regulation of Cyclin D1 Expression via Phosphatidylinositol 3-Kinase/Akt/Nuclear Factor-{kappa}B Cascade in Human Breast Cancer Cells
Endocrinology, November 1, 2005; 146(11): 4917 - 4925.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Ying, J. Marino, S. P. Hussain, M. A. Khan, S. You, A. B. Hofseth, G. E. Trivers, D. A. Dixon, C. C. Harris, and L. J. Hofseth
Chronic Inflammation Promotes Retinoblastoma Protein Hyperphosphorylation and E2F1 Activation
Cancer Res., October 15, 2005; 65(20): 9132 - 9136.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. D. Aupperlee, K. T. Smith, A. Kariagina, and S. Z. Haslam
Progesterone Receptor Isoforms A and B: Temporal and Spatial Differences in Expression during Murine Mammary Gland Development
Endocrinology, August 1, 2005; 146(8): 3577 - 3588.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Dietel, M.A. Lewis, and S. Shapiro
Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review
Hum. Reprod., August 1, 2005; 20(8): 2052 - 2060.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. J. Aiello, S. S. Tworoger, Y. Yasui, F. Z. Stanczyk, J. Potter, C. M. Ulrich, M. Irwin, and A. McTiernan
Associations among Circulating Sex Hormones, Insulin-Like Growth Factor, Lipids, and Mammographic Density in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1411 - 1417.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
Endocr. Rev., May 1, 2005; 26(3): 423 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Skildum, E. Faivre, and C. A. Lange
Progesterone Receptors Induce Cell Cycle Progression via Activation of Mitogen-Activated Protein Kinases
Mol. Endocrinol., February 1, 2005; 19(2): 327 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Y. Shi, J. P. Lydon, and M. Zhang
Hormonal Defect in Maspin Heterozygous Mice Reveals a Role of Progesterone in Pubertal Ductal Development
Mol. Endocrinol., September 1, 2004; 18(9): 2196 - 2207.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Ursin, S. L. Palla, B. A. Reboussin, S. Slone, C. Wasilauskas, M. C. Pike, and G. A. Greendale
Post-Treatment Change in Serum Estrone Predicts Mammographic Percent Density Changes in Women Who Received Combination Estrogen and Progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
J. Clin. Oncol., July 15, 2004; 22(14): 2842 - 2848.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. E. Wood, T. C. Register, M. S. Anthony, N. D. Kock, and J. M. Cline
Breast and Uterine Effects of Soy Isoflavones and Conjugated Equine Estrogens in Postmenopausal Female Monkeys
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3462 - 3468.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
ESHRE Capri Workshop Group
Hormones and breast cancer
Hum. Reprod. Update, July 1, 2004; 10(4): 281 - 293.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Pazol, M. E. Wilson, and K. Wallen
Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2998 - 3006.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. O. Lillie, L. Bernstein, S. A. Ingles, W. J. Gauderman, G. E. Rivas, V. Gagalang, T. Krontiris, and G. Ursin
Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy
Cancer Res., February 15, 2004; 64(4): 1237 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. A. Harvey and V. E. Bovbjerg
Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk
Radiology, January 1, 2004; 230(1): 29 - 41.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. M. Ahola, N. Alkio, T. Manninen, and T. Ylikomi
Progestin and G Protein-Coupled Receptor 30 Inhibit Mitogen-Activated Protein Kinase Activity in MCF-7 Breast Cancer Cells
Endocrinology, December 1, 2002; 143(12): 4620 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Vachon, T. A. Sellers, R. A. Vierkant, F.-F. Wu, and K. R. Brandt
Case-Control Study of Increased Mammographic Breast Density Response to Hormone Replacement Therapy
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1382 - 1388.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. M. Ahola, T. Manninen, N. Alkio, and T. Ylikomi
G Protein-Coupled Receptor 30 Is Critical for a Progestin-Induced Growth Inhibition in MCF-7 Breast Cancer Cells
Endocrinology, September 1, 2002; 143(9): 3376 - 3384.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Sunil, J. M. Bennett, and S. Z. Haslam
Hepatocyte Growth Factor Is Required for Progestin-Induced Epithelial Cell Proliferation and Alveolar-Like Morphogenesis in Serum-Free Culture of Normal Mammary Epithelial Cells
Endocrinology, August 1, 2002; 143(8): 2953 - 2960.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. M. Jacobsen, J. K. Richer, S. A. Schittone, and K. B. Horwitz
New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio Effects and Ligand-independent Gene Regulation
J. Biol. Chem., July 26, 2002; 277(31): 27793 - 27800.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C.-L. Chen, N. S. Weiss, P. Newcomb, W. Barlow, and E. White
Hormone Replacement Therapy in Relation to Breast Cancer
JAMA, February 13, 2002; 287(6): 734 - 741.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. J. Messina and C. L. Loprinzi
Soy for Breast Cancer Survivors: A Critical Review of the Literature
J. Nutr., November 1, 2001; 131(11): 3095S - 3108.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. J. Santen, J. Pinkerton, C. McCartney, and G. R. Petroni
Risk of Breast Cancer with Progestins in Combination with Estrogen as Hormone Replacement Therapy
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 16 - 23.
[Full Text]

Home page
 JNCI J Natl Cancer InstHome page
M. C. Pike and R. K. Ross
RESPONSE: Re: Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
J Natl Cancer Inst, December 6, 2000; 92(23): 1951 - 1952.
[Full Text] [PDF]

Home page
 JAMAHome page
L. A. Bazzano, G. Del Priore, M.-J. Lee, A. N. Glaser, J. A. Harvey, C. J. Newschaffer, K. J. Helzlsouer, C. A. Roca, P. J. Schmidt, R. C. Daly, et al.
Estrogen-Progestin Replacement and Risk of Breast Cancer
JAMA, August 9, 2000; 284(6): 691 - 694.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. K. Ross and M. C. Pike
RESPONSE: Re: Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
J Natl Cancer Inst, July 5, 2000; 92(13): 1100a - 1101a.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. An, C. Tzagarakis-Foster, T. C. Scharschmidt, N. Lomri, and D. C. Leitman
Estrogen Receptor beta -Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens
J. Biol. Chem., May 18, 2001; 276(21): 17808 - 17814.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society